Non-invasive Cancer Biomarkers Market Report

Global and Region Non-invasive Cancer Biomarkers Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：226
  • REPORT CODE：GMM1003876
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Noninvasive cancer biomarkers are the alternatives for the invasive tissue biopsies used for the detection of tumor presence in various cancer types. These biomarkers are used for detecting the state of disease. There are various types of biomarkers available such as circulation tumor DNA, serum micro RNAs, DNA methylation based biomarker, and protein based biomarkers and others.

    With large number of research and diagnostic laboratories as well as healthcare facilities, North America holds the largest market for the usage of these noninvasive cancer biomarkers for disease diagnosis and prognosis. This is followed by Europe with increasing academic as well as bio-pharmaceutical research activities and the advancement in healthcare facilities. Asia-Pacific is expected to be the growing market for the noninvasive cancer biomarkers because of increasing prevalence of different types of cancers and along with this, government support in the availability of healthcare facilities also supports the growth over the region.

    Increased cancer occurrence rate and development in the diagnosis and treatment is creating the market for noninvasive cancer biomarkers. Moreover, increased funding by various government as well as non-government organization in the oncology segment also supports the overall market. Availability of large number of kits in the market and the marketing strategies used by various manufacturers is creating competitive environment for the noninvasive cancer biomarkers market. Continuous research in this field also deepens the molecular understanding of cancer which increases the availability of biomarkers in the market.

    The report details the trend, potential and market size of Non-invasive Cancer Biomarkers market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Non-invasive Cancer Biomarkersmarket, defines the market attractiveness level of Non-invasive Cancer Biomarkers market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Non-invasive Cancer Biomarkers industry, describes the types of Non-invasive Cancer Biomarkers market, the applications of major players and the market size, and deeply analyzes the current situation of the global Non-invasive Cancer Biomarkers market and the development prospects and opportunities of Non-invasive Cancer Biomarkers industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Non-invasive Cancer Biomarkers market in Chapter 13.

    By Player:

    • Abbott

    • Thermo Fisher Scientific

    • Merck

    • Sino Biological

    • Roche

    • Bio-Rad

    By Type:

    • Protein Based Biomarkers

    • DNA Based Biomarkers

    • MRNA Based Biomarkers

    • Micro RNA Based Biomarkers

    By End-User:

    • Hospitals

    • Clinics

    • Diagnostic Laboratories

    • Academic and Research Institutes

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Non-invasive Cancer Biomarkers Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Non-invasive Cancer Biomarkers Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Non-invasive Cancer Biomarkers Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Non-invasive Cancer Biomarkers Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Non-invasive Cancer Biomarkers Market Analysis and Outlook to 2022

    • 7.1 Global Non-invasive Cancer Biomarkers Consumption (2017-2022)

    • 7.2 United States Non-invasive Cancer Biomarkers Consumption (2017-2022)

    • 7.3 Europe Non-invasive Cancer Biomarkers Consumption (2017-2022)

    • 7.4 China Non-invasive Cancer Biomarkers Consumption (2017-2022)

    • 7.5 Japan Non-invasive Cancer Biomarkers Consumption (2017-2022)

    • 7.6 India Non-invasive Cancer Biomarkers Consumption (2017-2022)

    • 7.7 South Korea Non-invasive Cancer Biomarkers Consumption (2017-2022)

    8 Region and Country-wise Non-invasive Cancer Biomarkers Market Analysis and Outlook to 2028

    • 8.1 Global Non-invasive Cancer Biomarkers Consumption Forecast (2022-2028)

    • 8.2 United States Non-invasive Cancer Biomarkers Consumption Forecast (2022-2028)

    • 8.3 Europe Non-invasive Cancer Biomarkers Consumption Forecast (2022-2028)

    • 8.4 China Non-invasive Cancer Biomarkers Consumption Forecast (2022-2028)

    • 8.5 Japan Non-invasive Cancer Biomarkers Consumption Forecast (2022-2028)

    • 8.6 India Non-invasive Cancer Biomarkers Consumption Forecast (2022-2028)

    • 8.7 South Korea Non-invasive Cancer Biomarkers Consumption Forecast (2022-2028)

    9 Global Non-invasive Cancer Biomarkers Market Outlook by Types and Applications to 2022

    • 9.1 Global Non-invasive Cancer Biomarkers Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Protein Based Biomarkers Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global DNA Based Biomarkers Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global MRNA Based Biomarkers Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Micro RNA Based Biomarkers Consumption and Growth Rate (2017-2022)

    • 9.2 Global Non-invasive Cancer Biomarkers Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Diagnostic Laboratories Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Academic and Research Institutes Consumption and Growth Rate (2017-2022)

    10 Global Non-invasive Cancer Biomarkers Market Outlook by Types and Applications to 2028

    • 10.1 Global Non-invasive Cancer Biomarkers Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Protein Based Biomarkers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global DNA Based Biomarkers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global MRNA Based Biomarkers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Micro RNA Based Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Non-invasive Cancer Biomarkers Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Diagnostic Laboratories Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Academic and Research Institutes Consumption Forecast and Growth Rate (2022-2028)

    11 Global Non-invasive Cancer Biomarkers Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Non-invasive Cancer Biomarkers Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Non-invasive Cancer Biomarkers Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Non-invasive Cancer Biomarkers Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Non-invasive Cancer Biomarkers Market Competitive Analysis

    • 14.1 Abbott

      • 14.1.1 Abbott Company Details

      • 14.1.2 Abbott Non-invasive Cancer Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Abbott Non-invasive Cancer Biomarkers Product and Service

    • 14.2 Thermo Fisher Scientific

      • 14.2.1 Thermo Fisher Scientific Company Details

      • 14.2.2 Thermo Fisher Scientific Non-invasive Cancer Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Thermo Fisher Scientific Non-invasive Cancer Biomarkers Product and Service

    • 14.3 Merck

      • 14.3.1 Merck Company Details

      • 14.3.2 Merck Non-invasive Cancer Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Merck Non-invasive Cancer Biomarkers Product and Service

    • 14.4 Sino Biological

      • 14.4.1 Sino Biological Company Details

      • 14.4.2 Sino Biological Non-invasive Cancer Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sino Biological Non-invasive Cancer Biomarkers Product and Service

    • 14.5 Roche

      • 14.5.1 Roche Company Details

      • 14.5.2 Roche Non-invasive Cancer Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Roche Non-invasive Cancer Biomarkers Product and Service

    • 14.6 Bio-Rad

      • 14.6.1 Bio-Rad Company Details

      • 14.6.2 Bio-Rad Non-invasive Cancer Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Bio-Rad Non-invasive Cancer Biomarkers Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Non-invasive Cancer Biomarkers

    • Figure Non-invasive Cancer Biomarkers Picture

    • Table Global Non-invasive Cancer Biomarkers Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Non-invasive Cancer Biomarkers Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Non-invasive Cancer Biomarkers Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Non-invasive Cancer Biomarkers Consumption by Country (2017-2022)

    • Figure United States Non-invasive Cancer Biomarkers Consumption and Growth Rate (2017-2022)

    • Table Europe Non-invasive Cancer Biomarkers Consumption and Growth Rate (2017-2022)

    • Figure China Non-invasive Cancer Biomarkers Consumption and Growth Rate (2017-2022)

    • Figure Japan Non-invasive Cancer Biomarkers Consumption and Growth Rate (2017-2022)

    • Figure India Non-invasive Cancer Biomarkers Consumption and Growth Rate (2017-2022)

    • Figure South Korea Non-invasive Cancer Biomarkers Consumption and Growth Rate (2017-2022)

    • Figure Global Non-invasive Cancer Biomarkers Consumption Forecast by Country (2022-2028)

    • Figure United States Non-invasive Cancer Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Non-invasive Cancer Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Non-invasive Cancer Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Non-invasive Cancer Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Non-invasive Cancer Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Non-invasive Cancer Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Protein Based Biomarkers Consumption and Growth Rate (2017-2022)

    • Figure Global DNA Based Biomarkers Consumption and Growth Rate (2017-2022)

    • Figure Global MRNA Based Biomarkers Consumption and Growth Rate (2017-2022)

    • Figure Global Micro RNA Based Biomarkers Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Laboratories Consumption and Growth Rate (2017-2022)

    • Figure Global Academic and Research Institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Protein Based Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DNA Based Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global MRNA Based Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Micro RNA Based Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Laboratories Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Academic and Research Institutes Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Non-invasive Cancer Biomarkers Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Non-invasive Cancer Biomarkers Export by Region (Top 5 Countries) (2017-2028)

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Non-invasive Cancer Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Non-invasive Cancer Biomarkers Product and Service

    • Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific Non-invasive Cancer Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Non-invasive Cancer Biomarkers Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Non-invasive Cancer Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Non-invasive Cancer Biomarkers Product and Service

    • Table Sino Biological (Foundation Year, Company Profile and etc.)

    • Table Sino Biological Non-invasive Cancer Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sino Biological Non-invasive Cancer Biomarkers Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Non-invasive Cancer Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Non-invasive Cancer Biomarkers Product and Service

    • Table Bio-Rad (Foundation Year, Company Profile and etc.)

    • Table Bio-Rad Non-invasive Cancer Biomarkers Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad Non-invasive Cancer Biomarkers Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US